HCA Healthcare, Inc. insider trading
HCAfinancial statementsForm 4 filings on EDGAR142 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at HCA Healthcare, Inc. bought $0 of stock in the open market, and 0 sold $0. Officers and directors accounted for $0 of purchases and $0 of sales. The last reported transaction was an other by McAlevey Michael R on August 26, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through August 28, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $0Aug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
142 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | otherindirect | 7,769 | $429.00 | $3M | 0 | Aug 28, 2026 |
| May 7, 2026 | Marks Mike A | EVP and CFO | gift | 3,336 | $0.00 | — | 0 | May 11, 2026 |
| May 7, 2026 | Marks Mike A | EVP and CFO | giftindirect | 3,336 | $0.00 | — | 46,576 | May 11, 2026 |
| Apr 28, 2026 | Frist William R | Director, 10% owner | award | 809 | $0.00 | — | 13,740 | Apr 30, 2026 |
| Apr 28, 2026 | Frist Thomas F III | Director, 10% owner | award | 1,041 | $0.00 | — | 15,858 | Apr 30, 2026 |
| Apr 28, 2026 | Smith Andrea B | Director | award | 509 | $0.00 | — | 4,666 | Apr 30, 2026 |
| Apr 28, 2026 | Riley Wayne Joseph | Director | award | 509 | $0.00 | — | 15,029 | Apr 30, 2026 |
| Apr 28, 2026 | Michelson Michael W | Director | award | 925 | $0.00 | — | 12,576 | Apr 30, 2026 |
| Apr 28, 2026 | Johnston Hugh F | Director | award | 809 | $0.00 | — | 4,475 | Apr 30, 2026 |
| Apr 28, 2026 | Deparle Nancy Ann | Director | award | 509 | $0.00 | — | 21,910 | Apr 30, 2026 |
| Apr 28, 2026 | Chidsey John | Director | award | 809 | $0.00 | — | 1,305 | Apr 30, 2026 |
| Feb 18, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | open-market sale | 1,694 | $533.37 | $904K | 8,853 | Feb 18, 2026 |
| Feb 13, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | tax withholding | 3,306 | $540.29 | $2M | 10,547 | Feb 18, 2026 |
| Feb 13, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | option exercise | 5,000 | $236.61 | $1M | 13,853 | Feb 18, 2026 |
| Feb 11, 2026 | Wyatt Christopher F. | SVP & Controller | open-market sale | 4,000 | $505.00 | $2M | 44,379 | Feb 12, 2026 |
| Feb 11, 2026 | Berres Jennifer | SVP & Chief Human Res. Officer | open-market sale | 4,010 | $526.16 | $2M | 11,993 | Feb 12, 2026 |
| Feb 11, 2026 | Berres Jennifer | SVP & Chief Human Res. Officer | open-market sale | 4,010 | $503.00 | $2M | 16,003 | Feb 12, 2026 |
| Feb 10, 2026 | Wyatt Christopher F. | SVP & Controller | award | 3,350 | $0.00 | — | 49,413 | Feb 12, 2026 |
| Feb 10, 2026 | Wyatt Christopher F. | SVP & Controller | tax withholding | 1,034 | $502.05 | $519K | 48,379 | Feb 12, 2026 |
| Feb 10, 2026 | Rossitto Erica | SVP & Chief Nurse Executive | tax withholding | 418 | $502.05 | $210K | 10,407 | Feb 12, 2026 |
| Feb 10, 2026 | Rossitto Erica | SVP & Chief Nurse Executive | award | 1,676 | $0.00 | — | 10,825 | Feb 12, 2026 |
| Feb 10, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | award | 8,372 | $0.00 | — | 11,859 | Feb 12, 2026 |
| Feb 10, 2026 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | tax withholding | 3,006 | $502.05 | $2M | 8,853 | Feb 12, 2026 |
| Feb 10, 2026 | Marks Mike A | EVP and CFO | tax withholding | 1,690 | $502.05 | $848K | 3,336 | Feb 12, 2026 |
| Feb 10, 2026 | Marks Mike A | EVP and CFO | award | 5,026 | $0.00 | — | 5,026 | Feb 12, 2026 |
| Feb 10, 2026 | Hazen Samuel N | CEO, Director | tax withholding | 21,323 | $502.05 | $11M | 64,842 | Feb 12, 2026 |
| Feb 10, 2026 | Hazen Samuel N | CEO, Director | award | 54,934 | $0.00 | — | 86,165 | Feb 12, 2026 |
| Feb 10, 2026 | Foster Jon M | EVP and COO | award | 15,696 | $0.00 | — | 28,950 | Feb 12, 2026 |
| Feb 10, 2026 | Foster Jon M | EVP and COO | tax withholding | 5,888 | $502.05 | $3M | 23,062 | Feb 12, 2026 |
| Feb 10, 2026 | Cuffe Michael S. | EVP and Chief Clinical Officer | tax withholding | 3,501 | $502.05 | $2M | 32,080 | Feb 12, 2026 |
| Feb 10, 2026 | Cuffe Michael S. | EVP and Chief Clinical Officer | award | 9,628 | $0.00 | — | 35,581 | Feb 12, 2026 |
| Feb 10, 2026 | Berres Jennifer | SVP & Chief Human Res. Officer | award | 7,116 | $0.00 | — | 22,528 | Feb 12, 2026 |
| Feb 10, 2026 | Berres Jennifer | SVP & Chief Human Res. Officer | tax withholding | 2,515 | $502.05 | $1M | 20,013 | Feb 12, 2026 |
| Feb 6, 2026 | Frist Thomas F JR | 10% owner | otherindirect | 37M | — | — | 37M | Feb 10, 2026 |
| Feb 6, 2026 | Frist Thomas F JR | 10% owner | otherindirect | 37M | — | — | 0 | Feb 10, 2026 |
| Feb 6, 2026 | Frist William R | Director, 10% owner | otherindirect | 37M | — | — | 0 | Feb 10, 2026 |
| Feb 6, 2026 | Frist William R | Director, 10% owner | otherindirect | 37M | — | — | 37M | Feb 10, 2026 |
| Feb 6, 2026 | Frist Thomas F III | Director, 10% owner | otherindirect | 37M | — | — | 0 | Feb 10, 2026 |
| Feb 6, 2026 | Frist Thomas F III | Director, 10% owner | otherindirect | 37M | — | — | 37M | Feb 10, 2026 |
| Feb 6, 2026 | Elcan Patricia F | 10% owner | otherindirect | 37M | — | — | 37M | Feb 10, 2026 |
| Feb 6, 2026 | Elcan Patricia F | 10% owner | otherindirect | 37M | — | — | 0 | Feb 10, 2026 |
| Feb 6, 2026 | Hercules Holding II | 10% owner | other | 37M | $0.00 | — | 32M | Feb 10, 2026 |
| Feb 6, 2026 | Frisco Holding II | 10% owner | other | 37M | — | — | 0 | Feb 10, 2026 |
| Feb 6, 2026 | Frisco Holding II | 10% owner | other | 37M | — | — | 37M | Feb 10, 2026 |
| Feb 5, 2026 | Wyatt Christopher F. | SVP & Controller | tax withholding | 5,674 | $513.76 | $3M | 46,063 | Feb 9, 2026 |
| Feb 5, 2026 | Wyatt Christopher F. | SVP & Controller | option exercise | 10,670 | $139.06 | $1M | 51,737 | Feb 9, 2026 |
| Feb 5, 2026 | Foster Jon M | EVP and COO | option exercise | 29,330 | $139.06 | $4M | 29,330 | Feb 9, 2026 |
| Feb 5, 2026 | Foster Jon M | EVP and COO | tax withholding | 16,076 | $513.76 | $8M | 13,254 | Feb 9, 2026 |
| Feb 4, 2026 | Hazen Samuel N | CEO, Director | otherindirect | 1,045 | $498.35 | $521K | 16,024 | Feb 5, 2026 |
| Feb 4, 2026 | Hazen Samuel N | CEO, Director | other | 1,045 | $498.35 | $521K | 31,231 | Feb 5, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Hazen Samuel N | CEO, Director | Feb 10, 2026 | tax withholding | 64,842 | — | $21M (7) | 0 of 7 |
| Berres Jennifer | SVP & Chief Human Res. Officer | Feb 11, 2026 | open-market sale | 11,993 | — | $4M (2) | 0 of 2 |
| McAlevey Michael R | EVP & Chief Legal & Admin Off. | Aug 26, 2026 | other | 8,853 | — | $3M (2) | 0 of 2 |
| Wyatt Christopher F. | SVP & Controller | Feb 11, 2026 | open-market sale | 44,379 | — | $2M (1) | 0 of 1 |
| Cuffe Michael S. | EVP and Chief Clinical Officer | Feb 10, 2026 | tax withholding | 32,080 | — | $747K (1) | 0 of 1 |
| Foster Jon M | EVP and COO | Feb 10, 2026 | award | 28,950 | — | — | — |
| Marks Mike A | EVP and CFO | May 7, 2026 | gift | 0 | — | — | — |
| Frist William R | Director, 10% owner | Apr 28, 2026 | award | 13,740 | — | — | — |
| Frist Thomas F III | Director, 10% owner | Apr 28, 2026 | award | 15,858 | — | — | — |
| Mosier Sammie S | SVP & Chief Nurse Executive | Feb 13, 2025 | tax withholding | 11,113 | — | — | — |
| Whalen Kathleen M | SVP & Chief Ethics Officer | Nov 14, 2024 | open-market sale | 9,454 | — | — | — |
| Billington Phillip G | SVP-Internal Audit Services | Nov 14, 2024 | open-market sale | 52,702 | — | — | — |
| Akdamar Erol R | Group President | Nov 14, 2024 | open-market sale | 6,843 | — | — | — |
| Smith Andrea B | Director | Apr 28, 2026 | award | 4,666 | — | — | — |
| Riley Wayne Joseph | Director | Apr 28, 2026 | award | 15,029 | — | — | — |
| Michelson Michael W | Director | Apr 28, 2026 | award | 12,576 | — | — | — |
| Johnston Hugh F | Director | Apr 28, 2026 | award | 4,475 | — | — | — |
| Deparle Nancy Ann | Director | Apr 28, 2026 | award | 21,910 | — | — | — |
| Chidsey John | Director | Apr 28, 2026 | award | 1,305 | — | — | — |
| Rossitto Erica | SVP & Chief Nurse Executive | Feb 10, 2026 | tax withholding | 10,407 | — | — | — |
| Frist Thomas F JR | 10% owner | Feb 6, 2026 | other | — | — | — | — |
| Elcan Patricia F | 10% owner | Feb 6, 2026 | other | — | — | — | — |
| Frisco Holding II | 10% owner | Feb 6, 2026 | other | 0 | — | — | — |
| Hercules Holding II | 10% owner | Feb 6, 2026 | other | 32M | — | — | — |
| Dennis Robert J | Director | Apr 29, 2025 | award | 26,601 | — | — | — |
Questions
Are HCA Healthcare, Inc. insiders buying or selling?
Over the twelve months to November 1, 2026, 5 insiders at HCA Healthcare, Inc. sold $31M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $31M. Only open-market purchases and sales are counted.
Who sold the most HCA Healthcare, Inc. stock in the last year?
Hazen Samuel N (CEO, Director) sold $21M in 7 open-market sales over the twelve months to November 1, 2026.
Do HCA Healthcare, Inc. executives sell under 10b5-1 plans?
0 of the 13 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on HCA Healthcare, Inc.
- HCA Healthcare, Inc. financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.